Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Wockhardt, Ltd.
WARNING LETTER
•Wockhardt, Ltd.•December 15, 2015

Wockhardt, Ltd. – FDA Warning Letter, Dec 15, 2015

Record Details

The FDA inspected Wockhardt Limited's drug manufacturing facility in Ankleshwar, Gujarat, India, from December 7-15, 2015, identifying significant CGMP violations for finished pharmaceuticals (21 CFR parts 210 and 211) and API deviations. Consequently, the firm's drugs are deemed adulterated under the FD&C Act. Key violations include the failure to establish and follow procedures to prevent microbiological contamination of sterile products, evidenced by airflow disturbances and aseptic technique breaches (21 CFR 211.113(b)). The firm also failed to ensure manufacturing personnel wore appropriate, undamaged clothing (21 CFR 211.28(a)). Laboratory records were incomplete, with unreported OOS results and excluded data (21 CFR 211.194(a)), and 12 computerized systems in the QC lab lacked validation (21 CFR 211.68(b)). Furthermore, activities were not recorded contemporaneously, and original CGMP records were destroyed. The FDA highlighted a systemic failure in data integrity, strongly recommending a qualified consultant for remediation. The firm must provide a detailed response within 15 working days, outlining comprehensive corrective and preventive actions. Business implications include the facility being placed on Import Alert 66-40, potential withholding of new drug application approvals, and continued refusal of admission for products into the U.S.

Company
Wockhardt, Ltd.
Inspection date
December 15, 2015
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Francis Godwin (Director)
View Company Profile

ID · a7f6ceea-4425-47f5-adcd-1a564d67201c

Violation Codes10
21 CFR 21021 CFR 21121 CFR 211.113(b)21 CFR 211.28(a)21 CFR 211.194(a)21 CFR 211.68(b)FD&C Act 501(a)(2)(B)FD&C Act 801(a)(3)21 U.S.C. 381(a)(3)21 U.S.C. 351(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Other documents for Wockhardt, Ltd.
  • 483 - 2015-12-15December 15, 2015

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Wockhardt, Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.